Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Dec;8(12):1739-54.
doi: 10.1586/erv.09.132.

DNA Vaccines for Biodefense

Affiliations
Review

DNA Vaccines for Biodefense

Lesley C Dupuy et al. Expert Rev Vaccines. .

Abstract

An ideal biodefense vaccine platform would allow for the quick formulation of novel vaccines in response to emerging or engineered pathogens. The resultant vaccine should elicit protective immune responses in one to three doses and be unaffected by pre-existing immunity to vaccine components. In addition, it should be amenable to combination and multi-agent formulation, and should be safe for all populations and the environment. DNA vaccines can potentially meet all of these requirements; thus, this platform is being tested with several biodefense threats. Here, we provide a review of the current status of the development efforts for DNA vaccines against several relevant biodefense pathogens: Bacillus anthracis, Ebola and Marburg viruses, smallpox virus, and Venezuelan equine encephalitis virus.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback